Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies (2022)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; RODRIGUES, LUCAS SILVA - FMRP ; ROSSI, GIORDANO NOVAK - FMRP ; ROCHA, JULIANA MENDES - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00406-021-01267-7
- Subjects: TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS; ALUCINOGÊNICOS; DROGAS DE ABUSO
- Keywords: Hallucinogens; Psychedelics ; Ayahuasca ; Dimethyltryptamine ; Harmine ; Harmaline ; Substance use disorders
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Archives of Psychiatry and Clinical Neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: on-line, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RODRIGUES, Lucas Silva et al. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-021-01267-7. Acesso em: 06 jun. 2024. -
APA
Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Osório, F. de L., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2022). Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience. doi:10.1007/s00406-021-01267-7 -
NLM
Rodrigues LS, Rossi GN, Rocha JM, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ;[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s00406-021-01267-7 -
Vancouver
Rodrigues LS, Rossi GN, Rocha JM, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ;[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s00406-021-01267-7 - Adverse effects after Ayahuasca administration in the clinical setting [Carta]
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test
- Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial
- The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
- The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: a systematic review of randomized controlled trials
Informações sobre o DOI: 10.1007/s00406-021-01267-7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
